Dermatology · The Villages, FL
NPI
1902811219
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
11950 County Road 101, Ste 203
The Villages, FL, 32162
Phone (352) 430-2580
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.6M
33,343 services
Medicare patients, 2024
1,641
Average age 78
Drug cost, 2024
$220K
654 prescriptions
Company payments, 2025
$250
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ashraf M Hassanein was code 17003 (destruction skin lesion), 6,070 times for 971 patients. In total Ashraf M Hassanein billed 33,343 services in 109 codes, and Medicare paid $2.6M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-01-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 6,070 | 971 | $4.71 | $29K |
| 88305 Surgical Pathology Examination | Office | 4,762 | 1,206 | $51.91 | $247K |
| 99213 Office E&M - Established | Office | 2,704 | 1,347 | $64.99 | $176K |
| 99212 Office E&M - Established | Office | 2,183 | 481 | $41.35 | $90K |
| 11103 Skin Biopsy | Office | 1,984 | 731 | $35.27 | $70K |
| 11102 Skin Biopsy | Office | 1,915 | 1,157 | $59.99 | $115K |
| 17000 Destruction Skin Lesion | Office | 1,852 | 1,099 | $31.95 | $59K |
| 77401 Conventional Radiation Treatment | Office | 1,662 | 104 | $29.58 | $49K |
| 77280 Radiation Treatment Planning | Office | 1,082 | 96 | $191.60 | $207K |
| 17311 Mohs Surgery | Office | 800 | 431 | $448.27 | $359K |
| 17004 Destruction Skin Lesion | Office | 795 | 494 | $113.06 | $90K |
| 17110 Destruction Skin Lesion | Office | 739 | 518 | $74.87 | $55K |
| 17312 Mohs Surgery | Office | 666 | 307 | $303.64 | $202K |
| 99214 Office E&M - Established | Office | 617 | 400 | $88.41 | $55K |
| G6001 Ultrasonic guidance for placement of radiation therapy fields | Office | 511 | 106 | $129.08 | $66K |
By year: 2022 $3.0M for 35,538 services; 2023 $3.0M for 35,646 services; 2024 $2.6M for 33,343 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 4,762 | 1,206 | $51.91 | $247K |
| 88341 Immunohistochemistry | 502 | 306 | $65.50 | $33K |
| 88342 Immunohistochemistry | 373 | 306 | $76.40 | $28K |
| 88304 Surgical Pathology Examination | 32 | 30 | $31.16 | $997 |
| 88312 Surgical Pathology Examination | 23 | 22 | $74.51 | $1,714 |
Medicare prescription drug claims, 2024
In 2024, the drug Ashraf M Hassanein prescribed most often to Medicare patients was Triamcinolone Acetonide, with 102 prescriptions and refills. In total Ashraf M Hassanein wrote 654 Medicare prescriptions that cost $220K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 102 | 108 | 80 | $903 |
| Ketoconazole Generic | 66 | 68 | 41 | $1,086 |
| Doxycycline Hyclate Generic | 60 | 61 | 46 | $699 |
| Clobetasol Propionate Generic | 42 | 42 | 28 | $1,076 |
| Mupirocin Generic | 37 | 37 | 34 | $274 |
| Cephalexin Generic | 36 | 36 | 35 | $310 |
| Metronidazole Generic | 29 | 42 | 18 | $1,264 |
| Hydrocortisone Generic | 25 | 29 | 23 | $176 |
| Clindamycin Phosphate Generic | 24 | 24 | 16 | $576 |
| Imiquimod Generic | 22 | 29 | 16 | $515 |
| Dupixent Pen Dupilumab | 21 | 21 | Under 11 | $78K |
| Gentamicin Sulfate Generic | 20 | 20 | 17 | $718 |
| Fluocinonide Generic | 16 | 16 | 14 | $537 |
| Clindamycin-Benzoyl Peroxide Clindamycin Phos/Benzoyl Perox | 14 | 14 | Under 11 | $5,290 |
| Enbrel Etanercept | 11 | 11 | Under 11 | $95K |
Brand drugs: 45 claims; generic drugs: 609 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ashraf M Hassanein $250 ($250 in general payments such as food, travel and fees) from 7 companies. The largest payer was Pfizer Inc. with $67.29.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.